Grifols, S.A Net Income 2012-2025 | GRFS

Grifols, S.A net income from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Grifols, S.A Annual Net Income
(Millions of US $)
2024 $170
2023 $64
2022 $219
2021 $223
2020 $707
2019 $700
2018 $705
2017 $749
2016 $604
2015 $591
2014 $621
2013 $454
2012 $328
2011 $70
Grifols, S.A Quarterly Net Income
(Millions of US $)
2025-09-30 $148
2025-06-30 $133
2025-03-31 $63
2024-09-30 $57
2024-06-30 $16
2023-06-30 $57
2023-03-31 $-116
2022-06-30 $96
2021-06-30 $165
2019-06-30 $194
2018-06-30 $209
2017-06-30 $158
2017-03-31 $143
2016-12-31 $150
2016-09-30 $158
2016-06-30 $157
2016-03-31 $138
2015-12-31 $144
2015-09-30 $156
2015-06-30 $147
2015-03-31 $145
2014-12-31 $149
2014-09-30 $151
2014-06-30 $139
2014-03-31 $168
2013-12-31 $104
2013-09-30 $112
2013-06-30 $121
2013-03-31 $118
2012-12-31 $76
2012-09-30 $80
2012-06-30 $85
2012-03-31 $87
2011-12-31 $9
2011-09-30 $35
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.642B 32.36
Takeda Pharmaceutical (TAK) Japan $56.448B 11.09
Zoetis (ZTS) United States $55.836B 19.98
BeOne Medicines - (ONC) Switzerland $38.601B 204.65
Daiichi Sankyo, - (DSNKY) Japan $35.368B 17.61
Sandoz Group AG (SDZNY) Switzerland $34.628B 0.00
United Therapeutics (UTHR) United States $20.779B 18.29
Merck (MKKGY) Germany $18.986B 11.70
Shionogi (SGIOY) Japan $18.324B 14.17
Ionis Pharmaceuticals (IONS) United States $13.766B 0.00
Neurocrine Biosciences (NBIX) United States $13.745B 32.98
IPSEN (IPSEY) France $13.548B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Summit Therapeutics (SMMT) United States $11.120B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.870B 0.00
Eisai (ESAIY) $8.306B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.149B 17.10
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.947B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.846B 0.00
Stevanato Group S.p.A (STVN) Italy $4.570B 25.58
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.536B 21.54
Indivior Pharmaceuticals (INDV) United States $4.293B 17.52
Corcept Therapeutics (CORT) United States $4.221B 45.60
NewAmsterdam Pharma (NAMS) Netherlands $3.740B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.361B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.080B 9.83
Hypermarcas (HYPMY) Brazil $3.002B 20.61
Dyne Therapeutics (DYN) United States $2.604B 0.00
Soleno Therapeutics (SLNO) United States $2.262B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.106B 0.00
Guardian Pharmacy Services (GRDN) United States $1.991B 38.34
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.922B 22.78
Ocular Therapeutix (OCUL) United States $1.822B 0.00
Ardelyx (ARDX) United States $1.793B 0.00
Harrow (HROW) United States $1.748B 107.27
Definium Therapeutics (DFTX) United States $1.678B 0.00
Enliven Therapeutics (ELVN) United States $1.651B 0.00
Oruka Therapeutics (ORKA) United States $1.598B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.524B 0.00
Collegium Pharmaceutical (COLL) United States $1.523B 7.54
Relay Therapeutics (RLAY) United States $1.472B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.353B 80.25
Evotec AG (EVO) Germany $1.322B 0.00
Xeris Biopharma Holdings (XERS) United States $1.175B 0.00
Savara (SVRA) United States $1.091B 0.00
Theravance Biopharma (TBPH) United States $1.018B 42.74
Aktis Oncology (AKTS) United States $1.009B 0.00
ARS Pharmaceuticals (SPRY) United States $1.002B 0.00
Cronos Group (CRON) Canada $0.985B 0.00
Xencor (XNCR) United States $0.823B 0.00
Esperion Therapeutics (ESPR) United States $0.818B 0.00
Nektar Therapeutics (NKTR) United States $0.766B 0.00
KalVista Pharmaceuticals (KALV) United States $0.757B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.730B 17.25
Bioventus (BVS) United States $0.670B 13.73
Rigel Pharmaceuticals (RIGL) United States $0.634B 5.66
Altimmune (ALT) United States $0.579B 0.00
ProKidney (PROK) United States $0.572B 0.00
4D Molecular Therapeutics (FDMT) United States $0.531B 0.00
Lexeo Therapeutics (LXEO) United States $0.531B 0.00
Lyell Immunopharma (LYEL) United States $0.514B 0.00
Zevra Therapeutics (ZVRA) United States $0.503B 0.00
Organogenesis (ORGO) United States $0.495B 0.00
Aquestive Therapeutics (AQST) United States $0.488B 0.00
Siga Technologies (SIGA) United States $0.482B 6.60
Nature's Sunshine Products (NATR) United States $0.453B 26.98
Elite Pharmaceuticals (ELTP) United States $0.423B 0.00
Aclaris Therapeutics (ACRS) United States $0.384B 0.00
USANA Health Sciences (USNA) United States $0.382B 10.66
Akebia Therapeutics (AKBA) United States $0.364B 0.00
Protara Therapeutics (TARA) United States $0.346B 0.00
Cybin (HELP) Canada $0.317B 0.00
Aldeyra Therapeutics (ALDX) United States $0.314B 0.00
Journey Medical (DERM) United States $0.280B 0.00
Larimar Therapeutics (LRMR) United States $0.272B 0.00
Relmada Therapeutics (RLMD) United States $0.268B 0.00
Avalo Therapeutics (AVTX) United States $0.266B 0.00
Enlivex Therapeutics (ENLV) Israel $0.261B 0.00
OmniAb (OABI) United States $0.250B 0.00
Profound Medical (PROF) Canada $0.248B 0.00
Heron Therapeutics (HRTX) United States $0.242B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Achieve Life Sciences (ACHV) Canada $0.224B 0.00
Context Therapeutics (CNTX) United States $0.211B 0.00
Silence Therapeutics (SLN) United Kingdom $0.203B 0.00
Surrozen (SRZN) United States $0.203B 0.00
Minerva Neurosciences (NERV) United States $0.202B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.198B 0.00
Galectin Therapeutics (GALT) United States $0.191B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
AleAnna (ANNA) United States $0.171B 0.00
Century Therapeutics (IPSC) United States $0.156B 0.00
VAXART, INC (VXRT) United States $0.151B 0.00
Prelude Therapeutics (PRLD) United States $0.145B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.141B 0.00
Unicycive Therapeutics (UNCY) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.124B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Korro Bio (KRRO) United States $0.115B 0.00
Karyopharm Therapeutics (KPTI) United States $0.115B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.114B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Vivani Medical (VANI) United States $0.103B 0.00
Incannex Healthcare (IXHL) Australia $0.099B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 38.71
Assertio Holdings (ASRT) United States $0.076B 0.00
PolyPid (PYPD) Israel $0.070B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Dominari Holdings (DOMH) United States $0.062B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 49.25
Fractyl Health (GUTS) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
BioNxt Solutions (BNXTF) Canada $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Acrivon Therapeutics (ACRV) United States $0.053B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Lipocine (LPCN) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.039B 0.00
Liminatus Pharma (LIMN) United States $0.039B 0.00
Talphera (TLPH) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Wellgistics Health (WGRX) United States $0.030B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Inotiv (NOTV) United States $0.015B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
China SXT Pharmaceuticals (SXTC) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00